XML 177 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated statement of changes in equity - USD ($)
$ in Millions
Total
Called up share capital and share premium
Other equity instruments
Retained earnings
[1],[2]
Financial assets at FVOCI reserve
Available-for-sale fair value reserve
[3]
Cash flow hedging reserve
Foreign exchange reserve
Merger and other reserves
[2],[4]
Total shareholders’ equity
Non-controlling interests
HSBC Holdings
HSBC Holdings
Called up share capital
HSBC Holdings
Share premium
HSBC Holdings
Other equity instruments
HSBC Holdings
Retained earnings
[5],[6]
HSBC Holdings
Financial assets at FVOCI reserve
HSBC Holdings
Available-for-sale fair value reserve
HSBC Holdings
Merger and other reserves
[6]
Equity beginning of period at Dec. 31, 2016 $ 182,578 $ 22,715 $ 17,110 $ 136,795   $ (477) $ (27) $ (28,038) $ 27,308 $ 175,386 $ 7,192 $ 104,858 $ 10,096 $ 12,619 $ 17,004 $ 27,656   $ 112 $ 37,371
Profit for the year 11,879     10,798           10,798 1,081 5,539       5,539      
Other comprehensive (expense)/income for the year, net of tax 9,383     328   131 (194) 8,966   9,231 152 (881)       (828)   (53)  
– available-for-sale investments 146         131       131 15 (53)           (53)  
– cash flow hedges (192)           (194)     (194) 2                
– changes in fair value of financial liabilities designated at fair value upon initial recognition arising from changes in own credit risk (2,024)     (2,024)           (2,024)   (828)       (828)      
– remeasurement of defined benefit asset/liability 2,419     2,395           2,395 24                
– share of other comprehensive income of associates and joint ventures (43)     (43)           (43)                  
– exchange differences 9,077             8,966   8,966 111                
Total comprehensive income for the year 21,262     11,126   131 (194) 8,966   20,029 1,233 4,658       4,711   (53)  
Shares issued under employee remuneration and share plans 56 622   (566)           56   570 38 584   (52)      
Shares issued in lieu of dividends and amounts arising thereon 3,206     3,206           3,206   3,205 190 (190)   3,205      
Capital securities issued 5,140 [7]   5,140 [7]             5,140 [7]   5,103     5,103        
Dividends to shareholders (12,211)     (11,551)           (11,551) (660) (11,551)       (11,551)      
Cost of share-based payment arrangements 500     500           500   (2)       (2)      
Cancellation of shares (3,000) [8] (3,000) [8]               (3,000) [8]   (3,000) (164) (2,836)          
Other movements 340     489   (4) (1)     484 (144) (54)       (64)     10
Equity end of period at Dec. 31, 2017 197,871 20,337 22,250 139,999 $ (350) [3] $ (350) (222) (19,072) 27,308 190,250 7,621 103,787 10,160 10,177 22,107 23,903 $ 59 $ 59 37,381
Profit for the year 15,025     13,727           13,727 1,298 52,825       52,825      
Other comprehensive (expense)/income for the year, net of tax (4,670)     2,765 (245) [3]   16 (7,061)   (4,525) (145) 865       865      
– debt instruments at fair value through other comprehensive income (243)       (245) [3]         (245) 2                
– equity instruments designated at fair value through other comprehensive income (27)                   (27)                
– available-for-sale investments                       0              
– cash flow hedges 19           16     16 3                
– changes in fair value of financial liabilities designated at fair value upon initial recognition arising from changes in own credit risk 2,847     2,847           2,847   865       865      
– remeasurement of defined benefit asset/liability (329)     (301)           (301) (28)                
– share of other comprehensive income of associates and joint ventures (64)     (64)           (64)                  
– effects of hyperinflation 283     283           283                  
– exchange differences (7,156)             (7,061)   (7,061) (95)                
Total comprehensive income for the year 10,355     16,492 (245) [3]   16 (7,061)   9,202 1,153 53,690       53,690      
Shares issued under employee remuneration and share plans 111 721   (610)           111   721 42 679   0      
Shares issued in lieu of dividends and amounts arising thereon 1,494     1,494           1,494   1,494 83 (83)   1,494      
Capital securities issued 5,968 [7]   5,968 [7]             5,968 [7]   5,967     5,967        
Dividends to shareholders (12,257)     (11,547)           (11,547) (710) (11,547)       (11,547)      
Redemption of securities (6,088) [9]   (5,851) [9] (237) [9]           (6,088) [9]   (6,079)     (5,843) (236)      
Transfers       (2,200) [10]         2,200 [10]             (2,200) [11]     2,200 [11]
Cost of share-based payment arrangements 450     450           450                  
Cancellation of shares (1,998) [8],[12] 2,731 [8],[12]   (4,998) [8],[12]         269 [8],[12] (1,998) [8],[12]   (1,998) [13] (105) [13] 2,836 [13]   (4,998) [13]     269 [13]
Other movements (10)     (67) 84 [3]         17 (27) 428       379     49
Equity end of period at Dec. 31, 2018 194,249 23,789 22,367 138,191 (1,532) [3]   (206) (26,133) 29,777 186,253 7,996 147,353 10,180 13,609 22,231 61,434 $ 0   39,899
Profit for the year 8,708     7,383           7,383 1,325 9,041       9,041      
Other comprehensive (expense)/income for the year, net of tax 1,017     (1,759) 1,424   204 1,000   869 148 (396)       (396)      
– debt instruments at fair value through other comprehensive income 1,152       1,146         1,146 6                
– equity instruments designated at fair value through other comprehensive income 366       278         278 88                
– available-for-sale investments                       0              
– cash flow hedges 206           204     204 2                
– changes in fair value of financial liabilities designated at fair value upon initial recognition arising from changes in own credit risk (2,002)     (2,002)           (2,002)   (396)       (396)      
– remeasurement of defined benefit asset/liability 13     5           5 8                
– share of other comprehensive income of associates and joint ventures 21     21           21                  
– effects of hyperinflation 217     217           217                  
– exchange differences 1,044     0       1,000   1,000 44                
Total comprehensive income for the year 9,725     5,624 1,424   204 1,000   8,252 1,473 8,645       8,645      
Shares issued under employee remuneration and share plans 62 557   (495)           62   501 36 521   (56)      
Shares issued in lieu of dividends and amounts arising thereon 2,687     2,687           2,687   2,687 171 (171)   2,687      
Capital securities issued                       0 0            
Dividends to shareholders (12,460)     (11,683)           (11,683) (777) (11,683)       (11,683)      
Redemption of securities (1,508) [9]   (1,496) [9] (12) [9]           (1,508) [9]   (1,508)     (1,488) (20)      
Transfers       2,475 [10]         (2,475) [10]             2,475 [11]     (2,475) [11]
Cost of share-based payment arrangements 478     478           478                  
Cancellation of shares (1,000) [8] (68) [8]   (1,000) [8]         68 [8] (1,000) [8]   (1,000) [14] (68) [14]     (1,000) [14]     68 [14]
Other movements 435     414           414 21 49     0 2     47
Equity end of period at Dec. 31, 2019 $ 192,668 $ 24,278 $ 20,871 $ 136,679 $ (108)   $ (2) $ (25,133) $ 27,370 $ 183,955 $ 8,713 $ 145,044 $ 10,319 $ 13,959 $ 20,743 $ 62,484     $ 37,539
[1] At 31 December 2019, retained earnings included 432,108,782 treasury shares (2018: 379,926,645; 2017: 360,590,019). In addition, treasury shares are also held within HSBC’s Insurance business retirement funds for the benefit of policyholders or beneficiaries within employee trusts for the settlement of shares expected to be delivered under employee share schemes or bonus plans, and the market-making activities in Global Markets.
[2] Cumulative goodwill amounting to $5,138m has been charged against reserves in respect of acquisitions of subsidiaries prior to 1 January 1998, including $3,469m charged against the merger reserve arising on the acquisition of HSBC Bank plc. The balance of $1,669m has been charged against retained earnings.
[3] The $350m at 31 December 2017 represents the IAS 39 available-for-sale fair value reserve as at 31 December 2017.
[4] Statutory share premium relief under section 131 of the Companies Act 1985 (the ‘Act’) was taken in respect of the acquisition of HSBC Bank plc in 1992, HSBC France in 2000 and HSBC Finance Corporation in 2003, and the shares issued were recorded at their nominal value only. In HSBC’s consolidated financial statements, the fair value differences of $8,290m in respect of HSBC France and $12,768m in respect of HSBC Finance Corporation were recognised in the merger reserve. The merger reserve created on the acquisition of HSBC Finance Corporation subsequently became attached to HSBC Overseas Holdings (UK) Limited (‘HOHU’), following a number of intra-Group reorganisations. During 2009, pursuant to section 131 of the Companies Act 1985, statutory share premium relief was taken in respect of the rights issue and $15,796m was recognised in the merger reserve.
[5] At 31 December 2019, retained earnings included 326,191,804 ($2,543m) of treasury shares (2018: 326,503,319 ($2,546m); 2017: 326,843,840 ($2,542m)).
[6] HSBC Holdings distributable reserves at 31 December 2019 of $31,656m (2018: $30,705m) represents realised profits for the year included in retained earnings of $11,516m (2018: $14,974m) and in merger reserve of $15,731m (2018: $15,731m). The distributable reserves are lower than retained earnings of $62,484m (2018: $61,434m). In 2018, $44,893m (2019: nil) represented income generated from restructuring the Group’s Asia operation to meet resolution and recovery requirements, which does not form part of distributable reserves.
[7] In 2018, HSBC Holdings issued $4,150m, £1,000m and SGD750m of perpetual subordinated contingent convertible capital securities on which there were $60m of external issuance costs, $49m of intra-Group issuance costs and $11m of tax benefits. In 2017, HSBC Holdings issued $3,000m, SGD1,000m and €1,250m of perpetual subordinated contingent convertible capital securities, on which there were $14m of external issuance costs, $37m of intra-Group issuance costs and $10m of tax benefits. Under IFRSs these issuance costs and tax benefits are classified as equity.
[8] For further details, refer to Note 31 in the Annual Report and Accounts 2019. In August 2019, HSBC announced a share buy-back of up to $1.0bn, which was completed in September 2019. In May 2018, HSBC announced a share buy-back of up to $2.0bn, which was completed in August 2018. In February 2017, HSBC announced a share buy-back of up to $1.0bn, which was completed in April 2017. In July 2017, HSBC announced a share buy-back of up to $2.0bn, which was completed in November 2017. Shares bought back from these buy-back programmes have been cancelled.
[9] During 2019, HSBC Holdings redeemed $1,500m 5.625% perpetual subordinated capital securities on which there were $12m of external issuance costs. In 2018, HSBC Holdings redeemed $2,200m 8.125% perpetual subordinated capital securities and its $3,800m 8.000% perpetual subordinated capital securities, Series 2, on which there were $172m of external issuance costs and $23m of intra-Group issuance costs wound down. Under IFRSs external issuance costs are classified as equity.
[10] Permitted transfers from the merger reserve to retained earnings were made when the investment in HSBC Overseas Holdings (UK) Limited was previously impaired. In 2018, a part reversal of this impairment resulted in a transfer from retained earnings back to the merger reserve of $2,200m. At 31 December 2019, an additional impairment of $2,475m was recognised and a permitted transfer of this amount was made from the merger reserve to retained earnings.
[11] Permitted transfers from the merger reserve to retained earnings were made when the investment in HSBC Overseas Holdings (UK) Limited was previously impaired. In 2018, a part reversal of this impairment resulted in a transfer from retained earnings back to the merger reserve of $2,200m. At 31 December 2019, an additional impairment of $2,475m was recognised and a permitted transfer of this amount was made from the merger reserve to retained earnings.
[12] This includes a re-presentation of the cancellation of shares to retained earnings and capital redemption reserve in respect of the 2017 share buy-back, under which retained earnings have been reduced by $3,000m, called up capital and share premium increased by $2,836m and other reserves increased by $164m.
[13] The 2018 year included a re-presentation of the cancellation of shares to retained earnings and capital redemption reserve in respect of the 2017 share buy-back, under which retained earnings has been reduced by $3,000m, share premium increased by $2,836m and other reserves increased by $164m.
[14] In August 2019, HSBC announced a share buy-back of up to $1.0bn, which was completed in September 2019.